ISMP Positions & Viewpoints

Comments to Pending Regulations

• PSO Comments to AHRQ

Federal Testimony and Presentations

• Summary of p resentation at the Food and Drug Administration's public meeting on Bar code labeling for drugproducts.
• Testimony before the Committee on Ways and Means Subcommittee on Health, Congress of the United States House of Representatives, hearing on Medicare Reform: Laying the Groundwork for a Prescription Drug Benefit.
• Testimony before the Committee on Health, Education, Labor and Pensions, United States Senate, hearing on Medical Errors: Understanding Adverse Drug Events.

White Papers/Discussion Papers

• A Call to Action: Protecting U.S. citizens from inappropriate medication use
• Since When Is It a Crime to Be Human? (Statement on Criminal Charges Filed Against Wisconsin Nurse Who Made a Fatal Medication Error)
• A Call to Action: Safeguard drug administration within 2 years! Bar coding of unit doses can reduce medication errors.
• A Call to Action: Eliminate handwritten prescriptions within 3 years! Electronic prescribing can reduce medication errors.
• Discussion paper on adverse event and error reporting in healthcare.

Select ISMP Medication Safety Alert!^® Articles

• Pharmaceutical industry and medical device companies: part of the solution?
• Our long journey toward a safety-minded just culture, part I: where we’ve been
• Our long journey toward a safety-minded just culture, part II: where we’re going
• ISMP comments on IOM report, preventing medication errors
• Safety requires a state of mindfulness, part I
• Safety requires a state of mindfulness, part II
• Mail service and community pharmacies must work in tandem
• welcome to the state board of (nursing, pharmacy, medicine) inquisitions
• New dangers in the drug reimportation process: Will we know what our patients are
• FDA and the pharmaceutical industry must be more responsive for a safer healthcare system
• Hospital and medical staff leadership is key to compliance with JC dangerous abbreviation list
• Evidence-based medicine doesn’t preclude common sense
• u cnt abbrv “Patient Safety”
• Atrocious labeling of plastic ampuls needs action now by FDA and manufacturers
• Lessons Lost by the Global Pharmaceutical Industry